Dosidal · Belgium
Constella 290 µg
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Belgium |
|---|---|
| Record | be:presentation:cti:431663-01 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | be-cti-extended: 431663-01 be-authorisation: EU/1/12/801/003 eu-number: EU/1/12/801/003 |
| Source authority | FAMHP |
| Read date | 2026-11-15T03:58:09Z |
| authorisation status | amp_status: AUTHORIZED ampp_status: AUTHORIZED commercialised_now: False lifecycle: history period_from: 2012-11-26 period_to: 2023-05-16 supply_problem_now: False state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| controlled status | state: unknown |
| identity | amp_code: SAM431645-00 atc: A03A authorisation_number: EU/1/12/801/003 cti_extended: 431663-01 form: Capsule, hard holder: AbbVie Deutschland medicine_type: ALLOPATHIC name: Constella 290 µg pack: 60 parallel_circuit: 0 parallel_import: False substances: strength: 290.0000 ug substance: Linaclotide state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| pack product code | fmd_in_scope: True note: no FMD product code and no CNK in SAM state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| prescription class | as_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006 class: prescription delivery_modus: M1 state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53-D75ED5-L7Xjfy5qWNlGWmPvUUimAH174FWe3YPE2lTsNYG1xi3zuYC47OdCk7bMZL2UNleBUY8ezdA7Fpuk4gVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:431663-01 · Same medicine in other markets · Dosidal